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Abstract
Background: A concept referred to as locomotive syndrome (LS) was proposed by the Japanese Orthopaedic
Association in order to help identify middle-aged and older adults who may be at high risk of requiring healthcare
services because of problems associated with locomotion. Cardiometabolic disorders, including obesity,
hypertension, diabetes, and dyslipidemia, have a high prevalence worldwide. The purpose of this study was to
determine the associations between LS and both body composition and cardiometabolic disorders.
Methods: The study participants were 165 healthy adult Japanese women volunteers living in rural areas. LS was
defined as a score ≥16 on the 25-question Geriatric Locomotive Function Scale (GLFS-25). Height, body weight,
body fat percentage, body mass index (BMI), and bone status were measured. Bone status was evaluated by
quantitative ultrasound (i.e., the speed of sound [SOS] of the calcaneus) and was expressed as the percent of Young
Adult Mean of the SOS (%YAM). Comorbid conditions of hypertension, hyperlipidemia, and diabetes were assessed
using self-report questionnaires.
Results: Twenty-nine participants (17.6 %) were classed as having LS. The LS group was older, shorter, and had a
higher body fat percentage, a higher BMI, and lower bone status than the non-LS group. Multiple logistic regression
analysis showed that participants with a BMI ≥23.5 kg/m2 had a significantly higher risk for LS than those with a
BMI <23.5 kg/m2 (odds ratio [OR] = 3.78, p < 0.01). Furthermore, GLFS-25 scores were higher in participants with than
those without hypertension, diabetes, or obesity, and significantly increased with the number of present disorders.
Conclusions: These findings suggest that BMI may be a useful screening tool for LS. Furthermore, because
hypertension and diabetes were associated with LS, the prevention of these disorders accompanied by weight
management may help protect against LS.
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Background
Japan is rapidly transforming into a super-aged society.
The Japanese Statistics Bureau reported that as of 2015,
individuals aged 65 years or older comprised 26.2 % of the
Japanese population [1]. Parallel with this transformation is
an increase in the incidence of health issues such as stroke,
senility, dementia, falls, fractures, and joint disorders, and in
turn, the number of individuals requiring nursing care [2].
Maintaining a healthy locomotive system, which in-
cludes the bone, cartilage, muscle, and nervous systems, is
the foundation of increased disability-free life expectancy.
It follows that, from a public health perspective, prevent-
ing the deterioration of motor function is an issue that
requires urgent attention. Therefore, an epidemiological
concept referred to as locomotive syndrome (LS) [2, 3]
has been proposed by the Japanese Orthopaedic Associ-
ation (JOA). LS primarily affects elderly individuals who
currently require nursing care services owing to problems
involving the locomotive system or those who have risk
conditions that will likely necessitate such services in the
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future [4]. LS is caused by the reduced muscle strength
and balance associated with aging and locomotive
pathologies including osteoporosis, osteoarthritis (OA),
and sarcopenia [2]. In females, LS may also be caused by
the decreasing levels of physical activity and bone mineral
density (BMD) that tend to occur after menopause. The
incidence of LS increases with age, and is significantly
higher in women (35.6 %) than in men (21.2 %) [5, 6]. As
beneficial locomotive exercises for the prevention of LS,
the JOA recommends performing “half-squats” and
“unipedal standing balance exercises with open eyes” [3].
The 25-question Geriatric Locomotive Function Scale
(GLFS-25), a quantitative and evidence-based screening
tool, can be used to identify individuals with LS [7, 8]. A
previous study reported finding a Spearman’s correlation
coefficient of 0.85 (p < 0.001) for the association between
GLFS-25 scores and the European Quality of Life 5
Dimensions Index (EQ-5D), indicating that the GLFS-25
had excellent concurrent validity [7].
Identifying factors associated with the development of
LS is crucial for its prevention. Results from a number
of recent studies suggest that GLFS-25 scores strongly
correlate with several physical performance measures,
including the unipedal standing balance and Timed Up
And Go tests [5, 9–13]. However, only a few reports
[5, 14] have focused on the association between the
development of LS and body composition, even though
numerous studies have reported that weight, body fat per-
centage, and BMD are associated with cardiovascular dis-
ease, various cancers, osteoporosis, hypertension, diabetes
and hyperlipidemia [15–21].
An association was recently reported between abdom-
inal obesity and LS in elderly Japanese women, suggesting
that waist circumference may be useful measure to assess
the risk for LS [22].
Metabolic syndrome comprises a combination of medical
disorders, including increased fasting plasma glucose,
abdominal obesity, high triglyceride levels, and high blood
pressure, that increase the risk of developing metabolic
conditions and cardiovascular disease [23]. In conjunction
with metabolic syndrome, obesity, hypertension, diabetes,
and dyslipidemia, which are known as the “deadly quartet,”
have a high prevalence worldwide [24]. Many studies have
reported that physical activity and body components are
associated with metabolic syndrome [17–21]. The propor-
tion of the Japanese population with LS (47 million) is
estimated to be more than twice that with metabolic
syndrome (20 million) [25, 26].
In the present study, we evaluated body composition
using body mass index (BMI), body fat percentage, and
bone status, and hypothesized that these variables would
be predictive of GLFS-25 scores. Confirmation of this
hypothesis would indicate that, in addition to sports
performance training, control of body composition could
be used to prevent LS. Therefore, the purpose of this
study was to determine the association between body
composition and LS, the threshold values of body
composition measures for discriminating between individ-
uals with and without LS, and the OR of LS according to
body composition above or below these thresholds in
elderly Japanese women living in rural areas. An additional




This study was conducted in a rural area (Tanabe city,
Wakayama Prefecture, Japan) between January 2013 and
March 2015. The study inclusion criteria were as follows:
1) Japanese women, age > 60 years; 2) ability to walk
independently; and 3) living at home and being capable of
self-care. All participants initially underwent body
composition measurements, in the order of height, weight,
and body fat percentage, followed by an evaluation of LS
status at a public hall where a “Lecture meeting and
checkup for health” was held with support from the local
government. Afterwards, 198 women were asked to
complete a self-report questionnaire at home regarding
comorbid conditions and then to return the questionnaire
by mail. A stamped envelope was provided to encourage
the return of the questionnaire. A total of 165 women
underwent the measurements and returned the question-
naire (mean age ± standard deviation, 68.8 ± 6.1 years;
range, 60–83 years).
Measurement of variables
Body weight and body fat percentage were measured using
the KaradaScan Body Composition Monitor with Scale
(HBF-362; Omron Co., Kyoto, Japan) while participants
were wearing normal indoor clothing. The procedure was
performed with the participants standing barefoot on a
metal surface in accordance with the manufacturer’s
instructions. BMI was calculated as weight divided by the
square of height, and obesity was defined as BMI ≥25 kg/
m2 in accordance with the guidelines of the Japan Society
for the Study of Obesity [27]. Bone status was assessed
using speed of sound (SOS) measured using a quantitative
ultrasound (QUS) device (Canon Life Care Solutions Inc.,
CM-200, Osaka, Japan) at the calcaneus of the dominant
foot while the participants were barefoot and seated. QUS,
which has a number of advantages, including portability,
low cost, and a lack of exposure to radiation [28], enables
the evaluation of bone quality, especially the microarchi-
tecture at the calcaneus, and is useful for predicting risk
for future fracture [29]. Bone status was shown as the
percent of Young Adult Mean of the SOS (%YAM) [30]. It
has been reported that calcaneal QUS parameters reflect
the characteristics of the trochanteric area of the proximal
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hip, although these values are not specifically reflective of
values of the femoral neck or shaft [31].
Evaluation of LS
LS status (presence and degree) was evaluated based on
GLFS-25 scores (Additional file 1). The GLFS-25 is a self-
report questionnaire composed of the following 25 items
focusing on the month before completing the measure: four
questions on pain; 16 on activities of daily living; three on
social function; and two on mental health status [7]. These
25 items are scored from 0 (no impairment) to 4 (severe
impairment), with a total score range from 0 to 100. Higher
scores indicate worse locomotive function. The cutoff score
for LS, as determined by receiver operating characteristic
(ROC) analysis, is 16 points [7].
Comorbid conditions
Comorbid conditions of hypertension, hyperlipidemia,
and diabetes were assessed using the following question
on the self-report questionnaire: “Do you presently take
medication for hypertension, diabetes, or hyperlipidemia?”
Statistical analysis
Participants were classified as LS (≥16) or non-LS (<16)
based on GLFS-25 scores, and then independent
variables were compared between groups. For numerical
variables, normality of distribution and homogeneity of
variance were tested before across-group comparisons.
When the assumptions of normal distribution and
homogeneity of variance were met in both groups, we
performed the student t-test, and when the assumption of
normal distribution was met, but not the assumption of
homogeneity of variance, we performed Welch’s t-test.
When the data were non-normally distributed, the
Wilcoxon signed-rank test was used.
ROC analysis was used to evaluate the threshold of
each body composition measure (BMI, body fat percent-
age, and %YAM) in order to discriminate the LS from
the non-LS group. An area under the ROC (AUC-ROC)
curve of 1.00 was taken to indicate perfect discrimin-
ation, whereas an AUC-ROC of 0.50 was taken to indi-
cate the complete absence of discrimination.
Multiple logistic regression analysis was performed to
evaluate the age-adjusted significance of the prevalence
of LS. The chi-square test was used for comparison of
prevalence or number of cardiometabolic disorders
between non-LS and LS. The Wilcoxon signed-rank test
was used for comparison of GLFS-25 scores classified by
with and without cardiometabolic disorders, as well as
by the number of present disorders. Statistical analysis
was conducted using JMP 11 (SAS Institute, Cary, NC).
All statistical tests were 2-tailed, and a significance level
of 0.05 was used.
Results
Age, height, body weight, body fat percentage, BMI, bone
status, GLFS-25 score, and the prevalence of components
of cardiometabolic disorder are shown in Table 1. Twenty-
nine participants (17.5 %) had a GLFS-25 score ≥16 and
were thereby classified as LS (Table 2). The LS group
was older and shorter than the non-LS group, and
had a higher body fat percentage, a higher BMI, and
lower bone status (Table 2).
ROC analysis was conducted for each body composition
measure, and the threshold for discriminating the non-LS
and LS groups was identified. This threshold was 37.3 %
for body fat percentage, 23.5 kg/m2 for BMI, and 73 % for
%YAM (Table 3). ORs for the prevalence of LS according
to the threshold values are shown in Table 4. High BMI
was a significant risk factor for LS, with an OR of 3.78 as
determined by multiple logistic regression analysis.
Figure 1 shows GLFS-25 scores classified by the presence
or absence of each metabolic syndrome component (hyper-
tension, diabetes, hyperlipidemia, and obesity). GLFS-25
scores were higher in participants with than without
hypertension or diabetes, and in obese than in non-obese
participants. Figure 2 shows GLFS-25 scores classified by
the number of present cardiometabolic disorders. The re-
sults showed that GLFS-25 scores significantly increased
with the number of cardiometabolic disorders (p < 0.01).
Table 5 shows a comparison of the prevalence or number
of cardiometabolic disorders between non-LS and LS sub-
jects. The prevalence of LS was higher in participants with
than without hypertension (p < 0.05) and obesity (p < 0.01).
Discussion
Association between body composition and LS
LS was proposed by the JOA in 2007 in order to identify
individuals at high risk of requiring nursing care owing
Table 1 Characteristics of the study participants
Variables for components Mean (SDa)
Age (years) 68.8 (6.1)
Height (cm) 150.4 (11.9)
Weight (kg) 52.9 (8.3)
Body fat percentage (%) 33.9 (4.5)
BMI (kg/m2) 23.1 (3.6)
%YAMb (%) 69.8 (11.0)
GLFS-25 score (points) 10.0 (10.3)
Components of cardiometabolic disorders Prevalence (%)
Obesity 45 (27.3)
Hypertension 59 (35.8)
Diabetes mellitus 12 (7.3)
Hyperlipidemia 23 (13.9)
aSD standard deviation
bYAM percent of Young Adult Mean of the speed of sound of the calcaneus
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to problems associated with the locomotive system [2].
The GLFS-25 was subsequently developed to measure
the presence and degree of LS in Japanese individuals
[7]. However, since its implementation, the GLFS-25
cutoff value for identifying individuals with LS has been
determined in accordance with health-related quality of
life [7, 11]; therefore, information on the association
between GLFS-25 scores and body composition is
limited. Therefore, the primary purpose of this study
was to determine the association between LS as defined
by GLFS-25 scores and body composition measures in
elderly Japanese women.
Our results showed that participants with LS were
shorter, had a higher body fat percentage, a higher BMI,
and lower bone status than participants without LS. Previ-
ous studies have reported similar results in middle-aged
and elderly Japanese women [5, 14]. Muramoto et al.
found that GLFS-25 scores had a significant positive
correlation with body fat percentage and BMI, a negative
correlation with body height and BMD, and no correlation
with body weight according to correlation analysis [5].
Based on comparative analysis, participants with LS
have been shown to have significantly greater BMI and
body fat percentage and lower height than those without
LS, whereas no significant difference has been observed
in body weight or BMD [14].
In the present study, we found that participants with LS
were shorter than those without LS. Shorter height has
been reported to be significantly associated with fear of
falling in elderly Japanese individuals [32]. Shorter height
may be caused by an age-related change in the curvature of
the spine or atrophy of trunk extension muscles, which can
decrease postural control. A reduction in postural control
can cause fear of falling or a decline in the amount of phys-
ical activity [33]. Therefore, we propose that the LS group
included more participants that had lost height due to a
change in the curvature of the spine or atrophy of trunk
extension muscles than the non-LS group, and therefore
had less postural control and engaged in fewer activities in
daily life, which increased their risk for developing LS.
The present results showed that participants with LS
had a higher body fat percentage than those without LS.
Increased body fat causes more mechanical stress in
weight-bearing joints and promotes the degeneration of
joint tissue through the production and release of adipo-
kines [34]. Adipokines are derived from adipocytes and
may upregulate receptor activators of nuclear kappa B
ligand, leading to increased bone resorption and reduced
BMD [35]. Participants with a higher body fat percent-
age may have secreted more adipocytes, and this may
have had a negative influence on the movement of the
joints, thereby increasing the risk of LS.
The present study showed that a BMI ≥23.5 k/m2 was
significantly associated with LS, with an OR of 3.78 as
identified by multiple logistic regression analysis. The Japan
Society for the Study of Obesity defines the cutoff for
obesity as a BMI 25 kg/m2 [8]. In the present study, the
mean BMI of the participants with LS was ≥25 kg/m2.
Furthermore, GLFS-25 scores were higher in obese than in
non-obese participants (Fig. 2d). LS is closely associated with
age-related skeletal disorders such as osteoporosis, OA, lum-
bar spinal stenosis (LSS), degenerative spinal disease and
sarcopenia [4]. Furthermore, obesity is a risk factor for these
disorders because mechanical overload on weight-bearing
joints can activate chondrocytes, accelerate the degeneration
of cartilage, and increase static compressive loading and







Age (years) 68.1(5.9) 72.1(6.0) 0.0014e
Height (cm) 151.9(5.0) 143.7(25.5) 0.0015e
Weight (kg) 52.3(8.3) 55.4(8.3) 0.0730f
Body fat percentage (%) 33.4(4.3) 36.3(4.6) 0.0020e
BMI (kg/m2) 22.7(3.1) 25.2(3.7) 0.0007e
%YAMd (%) 70.6(11.4) 65.7(8.3) 0.0288f
aLocomotive Syndrome: GLFS-25 score ≥16 points
bNon-LS non-locomotive syndrome
cLS locomotive syndrome
dYAM percent of Young Adult Mean of the speed of sound of the calcaneus
eWilcoxon signed-rank test was applied for age, height, body fat percentage,
and BMI
fStudent’s t-test was applied for weight and YAM




AUCa Sensitivity (%) Specificity (%)
Body fat
percentage (%)
37.3 0.68 51.72 68.13
BMI (kg/m2) 23.5 0.70 72.41 67.29
%YAMb (%) 73.0 0.61 86.21 79.23
aAUC area under the curve
bYAM percent of Young Adult Mean of the speed of sound of the calcaneus
Table 4 Evaluation of odds ratios for locomotive syndrome
according to body composition
Above or below the
threshold value





BMI (kg/m2) <23.5 1 0.0087
≥23.5 3.78 (1.39–11.07)
%YAMb (%) <73 1.68 (0.65–4.73) 0.2900
≥73 1
aCI confidence interval
bYAM percent of Young Adult Mean of the speed of sound of the calcaneus
Data were adjusted by age
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pressures associated with postures that damage disc integrity
[36–38]. Moreover, it has been proposed that metabolic
factors, including inflamed adipose tissue, dyslipidemia,
oxidative stress, endothelial dysfunction and leptin dysregu-
lation, as well as the clustering of these factors in metabolic
syndrome, may play a crucial role in obesity-induced OA
[39–41]. These findings support the present results regard-
ing the association between obesity and LS.
Association between LS and cardiometabolic disorders
Obesity, hypertension, diabetes, and dyslipidemia are
known as the “deadly quartet” [24]. Numerous studies
have reported that BMD is associated with these disor-
ders [17–21]. The second purpose of the present study
was to determine the association between LS and cardio-
metabolic disorders. Our results showed that LS is asso-
ciated with hypertension, diabetes, and overweight, as
well as with higher BMI. Furthermore, GLFS-25 scores
significantly increased with the number of present car-
diometabolic disorders.
There are some reports on the association between car-
diometabolic disorders and OA. Some evidence suggests
Fig. 1 GLFS-25 scores in participants with and without hypertension (a), diabetes (b), hyperlipidemia (c), and obesity (d). HT, hypertension; NHT,
non-hypertension; DM, diabetes mellitus; NDM, non-diabetes mellitus; HL, hyperlipidemia; NHL, non-hyperlipidemia; OB, obesity (BMI ≥25 kg/m2);
NOB, non-obesity (BMI <25 kg/m2); *p < 0.05; **p < 0.01; error bars, standard deviation
Fig. 2 GLFS-25 scores in participants with 0, 1, 2, and ≥3 present
cardiometabolic disorders. A significant main effect was observed for
the number of disorders (p < 0.01; analysis of variance). *p < 0.05;
**p < 0.01; error bars, standard deviation
Table 5 Comparison of prevalence or number of present
cardiometabolic disorders between non-locomotive and
locomotive syndromea
Non-LSb LSc P value
NHTd (153) 128 (83.7 %) 25 (16.3 %) 0.0482
HTe (12) 8 (66.7 %) 4 (33.3 %)
NDMf (142) 116 (81.7 %) 26 (18.3 %) 0.1364
DMg (23) 20 (87.0 %) 3 (13.0 %)
NHLh (106) 92 (86.8 %) 14 (13.2 %) 0.5382
HLi (59) 44 (74.6 %) 15 (25.4 %)
NOBj (120) 106 (88.3 %) 14 (11.7 %) 0.0011




0 (76) 67 (88.2 %) 9 (11.8 %) 0.0526
1 (52) 44 (84.6 %) 8 (15.4 %)
2 (26) 18 (69.2 %) 8 (30.8 %)
≥3 (11) 7 (63.6 %) 4 (36.4 %)
aLocomotive Syndrome: GLFS-25 score ≥16 points; bNon-LS non-locomotive
syndrome, cLS locomotive syndrome, dNHT non-hypertension, eHT hypertension,
fNDM non-diabetes, gDM diabetes, hNHL non-hyperlipidemia, iHL hyperlipidemia,
jNOB non-obesity (BMI <25 kg/m2), kOB obesity (BMI ≥25 kg/m2)
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that metabolic factors such as type 2 diabetes mellitus and
elevated glucose concentration are associated with the
development and progression of OA [40, 42]. In particular,
the advanced glycation end products in cartilage collagen
seem to be associated with both the senescent cartilage
matrix and reduced chondrocyte function [43]. The pres-
ence of advanced glycation end products associated with
the expression of advanced glycation end-product receptors
in the cartilage collagen results in the increased production
of matrix metalloproteinase and the modulation of the
chondrocyte phenotype to hypertrophy and OA [44, 45].
OA and hypertension have been shown to frequently
coexist [46]. The proposed mechanism of the develop-
ment of OA with hypertension is as follows: narrow and/
or constricted vessels restrict blood flow to subchondral
bone, impairing circulation and nutritional supply to over-
lying articular cartilage, which ultimately contributes to
the deterioration of cartilage in OA [47].
Mutual relations exist between the occurrence and
presence of musculoskeletal diseases, particularly knee
OA and cardiometabolic disorders [48]. Yoshimura et al.
suggested that metabolic risk factors such as overweight,
hypertension, hyperlipidemia, and impaired glucose
tolerance increase the risk of occurrence and progression
of knee OA [49, 50]. Recent reports have indicated that
waist circumference, back muscle strength, and spinal
inclination angle are important risk factors for LS [22]. In
the present study, we demonstrated that LS is associated
with hypertension and obesity, as well as a higher BMI.
Furthermore, GLFS-25 scores significantly increased with
the number of present cardiometabolic disorders. These
findings suggest a close relationship between the locomo-
tive system and cardiometabolic organs.
The proportion of adults with BMI >25 kg/m2 has
significantly increased worldwide [51]. The present findings
contribute to the identification of factors that may prevent
locomotive disorder and metabolic syndrome, particular in
Western societies, in which many patients have metabolic
syndrome. Although the concept of LS is currently used
only in Japan, we believe it will become more common
worldwide as the population continues to age.
The results of the present study suggest that BMI might
be a useful measure for the simple detection of LS.
Furthermore, hypertension and diabetes were found to be
associated with LS. Weight management and prevention
of these disorders may help protect against LS in elderly
women. Elderly men should be included in future studies.
Limitations and future research
This study did have several limitations. First, the sample
size of 165 was small; this number only represents about
1.2 % of all women aged between 60 and 83 years in Tanabe
city. Furthermore, no significant relationship was found
between LS and dyslipidemia; this may have been due in
part to a lack of statistical power. Second, because the
participants in this study were all Japanese women, care
should be taken in generalizing the results to men or other
ethnic groups. Third, data from a cross-sectional study are
not sufficient to determine whether a causal relationship
exists between BMI, LS, and cardiometabolic disorders. LS
may cause obesity or hypertension and diabetes because it
limits physical activity. Conversely, these cardiometabolic
disorders may lead to the development of LS. It is therefore
crucial to perform longitudinal studies to clarify the causal
relationships among these factors. Fourth, comorbid condi-
tions were only assessed using self-report questionnaires;
therefore, blood pressure, blood glucose concentration, and
blood lipid concentration measurements were not con-
trolled. Thus, untreated participants with comorbid condi-
tions may have been excluded from analysis; however, this
possibility is low because participants attending the “Lec-
ture meeting” would have been expected to have relatively
high health awareness. Fifth, further research in larger-sized
studies should measure lean mass because it is an import-
ant component of BMI. It is possible that BMI underesti-
mates body fat percentage in clinical populations [52].
Conclusion
BMI, body fat percentage, and bone status were signifi-
cantly associated with LS. In particular, a BMI ≥23.5 k/m2
was significantly associated with LS. Moreover, GLFS-25
scores were higher in participants with a BMI ≥25 kg/m2,
hypertension, and diabetes than in the respective compari-
son groups. These results suggest that BMI is an import-
ant measure for the detection of LS. Furthermore, weight
management and the prevention of metabolic syndrome
may reduce the risk for LS.
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